Loading...
Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Loading...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Swertia chirayita
Herbe himalayenne extrêmement amère utilisée en ayurveda pour la fièvre, les troubles du foie et la purification du sang.
Chirata (Swertia chirayita) is an intensely bitter Himalayan herb traditionally used in Ayurveda for fever, liver disorders, and blood purification. Its key active compounds include swerchirin, swertianolin, amarogentin, swertiamarin, and mangiferin, which contribute to its antipyretic, hepatoprotective, and antidiabetic properties.
The bitter principles (e.g., amarogentin, swertiamarin) stimulate bitter taste receptors (TAS2Rs) in the oral cavity and gut, leading to increased secretion of digestive enzymes and bile, thereby enhancing liver function and detoxification. Swerchirin and mangiferin exhibit hypoglycemic effects by enhancing insulin secretion and improving peripheral glucose uptake via AMPK activation. Additionally, these compounds possess antioxidant and anti-inflammatory activities through modulation of NF-κB and Nrf2 pathways, contributing to antipyretic and hepatoprotective actions.
Herbe himalayenne extrêmement amère utilisée en ayurveda pour la fièvre, les troubles du foie et la purification du sang.
Chirata (Swertia chirayita) is an intensely bitter Himalayan herb traditionally used in Ayurveda for fever, liver disorders, and blood purification. Its key active compounds include swerchirin, swertianolin, amarogentin, swertiamarin, and mangiferin, which contribute to its antipyretic, hepatoprotective, and antidiabetic properties.
The bitter principles (e.g., amarogentin, swertiamarin) stimulate bitter taste receptors (TAS2Rs) in the oral cavity and gut, leading to increased secretion of digestive enzymes and bile, thereby enhancing liver function and detoxification. Swerchirin and mangiferin exhibit hypoglycemic effects by enhancing insulin secretion and improving peripheral glucose uptake via AMPK activation. Additionally, these compounds possess antioxidant and anti-inflammatory activities through modulation of NF-κB and Nrf2 pathways, contributing to antipyretic and hepatoprotective actions.